Previous close | 5,174.00 |
Open | 5,391.69 |
Bid | 0.00 x N/A |
Ask | 5,850.00 x N/A |
Day's range | 5,391.69 - 5,416.00 |
52-week range | 4,990.00 - 9,502.45 |
Volume | |
Avg. volume | 162 |
Market cap | 679.935B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 19.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 60.32 (1.17%) |
Ex-dividend date | 28 Jun 2024 |
1y target est | N/A |
Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
Recently, Zacks.com users have been paying close attention to Humana (HUM). This makes it worthwhile to examine what the stock has in store.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.